Home > Insider Trading > Filing (0001144204-13-047162)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1289340	Stereotaxis Inc.	STXS	Electromedical & Electrotherapeutic Apparatus (3845)	943120386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1299430	D Christopher Alafi	P.o. Box 7338 Berkeley CA 94707		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-08-16	261,241	$3.36	1,527,869	No	4	M	Indirect	Alafi Capital Company LLC
Common Stock	Disposition	2013-08-19	239,021	$3.74	1,288,848	No	4	S	Indirect	Alafi Capital Company LLC
Common Stock	Disposition	2013-08-20	22,220	$3.70	1,266,628	No	4	S	Indirect	Alafi Capital Company LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	Alafi Capital Company LLC
No	4	S	Indirect	Alafi Capital Company LLC
No	4	S	Indirect	Alafi Capital Company LLC

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant (right to buy)	Disposition	2013-08-16	261,241	$3.36	261,241	$3.36

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
606,249	2012-05-10	2017-05-10	No	4	M	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	24,593	Direct
Common Stock	12,600	Indirect	Christopher Alafi Trust
Common Stock	222	Indirect	Alafi Family Foundation
Common Stock	3,000	Indirect	by Mother

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.